Arkolith/Insider Trading/ACXP/Form 4

Luci David P

President and CEO, Director, 10% OwnerAcurx Pharmaceuticals, Inc. (ACXP) · full profile →Form 4 · filed Jul 29, 2022
Net Buying
Open-Market Buys
$75K
Open-Market Sells
$0
Net Open-Market Flow
$75K
Transactions
3
1 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 27, 2022Buy(P)20K$3.80$75K1.0M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 27, 2022Buy(P)20K—$020K
Jul 27, 2022Buy(P)20K—$020K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-22-084315) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Acurx Pharmaceuticals, Inc.

Build

Ask your agent about ACXP insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001104659-22-084315"
Ask your agent
Use Arkolith to summarize insider buying and selling at Acurx Pharmaceuticals, Inc.
over the last 90 days and cite the filings.